Christopher J. McLeod
Quick facts
Marketed products
- PEP · Infectious disease
PEP is an antiretroviral medication that inhibits the replication of retroviruses by blocking the action of the viral protease enzyme.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: